CBD for ADHD (attention deficit/hyperactivity disorder) may be another beneficial use for cannabinoids. Scientists across the world have been conducting studies related to CBD treatment for ADHD. Consequently, medical professionals have developed more of an understanding of how the endocannabinoid system impacts neurotransmitters that control levels of hyperactivity.
According to the Attention Deficit Disorder Association, at least 11 million Americans suffer from ADHD. Medical professionals believe ADHD is genetic, although there are a variety of contributing factors. Scientists also know that ADHD is a syndrome that is based in the brain. This syndrome affects a very particular set of behaviors. Patients with ADHD display signs of inattentiveness. For example, they may lose focus very easily and have trouble remembering what they heard. Furthermore, they may lack organizational skills, be prone to mistakes, or have a variety of other problems ranging from learning disabilities and poor social skills to hyperactivity or impulsivity and lack of motivation.
One of the basis for theory that CBD for ADHD would be effective stems from knowledge that ADHD is one of the primary conditions for which patients seek cannabis therapy. (https://www.ncbi.nlm.nih.gov/pubmed/27033880)
Studies on CBD for ADHD show promise.
European Neuropsychopharmacology published a study related to CBD for ADHD (https://www.europeanneuropsychopharmacology.com/article/S0924-977X(16)30912-9/pdf)
In this study, a research team divided 30 patients with ADHD into two groups. One group received Sativex – a CBD-based medication. Conversely, the other group received a placebo. The group who received Sativex showed a slight improvement of symptoms. Although the improvement was not significant with Sativex, scientist still learned that CBD has a positive impact on individuals suffering from ADHD. With this in mind, different levels of CBD can be tested as treatment for ADHD.
CBD for ADHD works to reduce social interaction deficits and ease symptoms of hyperactivity.
A group of researchers in Australia conducted a study on CBD for ADHD. (https://www.ncbi.nlm.nih.gov/pubmed/22495620)
In this study, lab technicians treated rats with an MK-801 solution. MK-801 is a known antagonist to the NMDA (N-Methyl-D-aspartate) receptor. Scientists know the NMDA receptor is responsible for a variety of psychiatric conditions. MK-801 was used to induce social deficits and hyperactivity. After treating the rats with MK-801, scientists, then, treated them with CBD. They noted that CBD reversed the deficits caused by the MK-801. Furthermore, the rats displayed fewer symptoms of hyperactivity. Therefore, cannabinoids are effective in inhibiting activity in the NMDA receptor that contributes to social dysfunction and hyperactivity.
Scientists are still conducing more research on CBD for ADHD. We will be updating you accordingly.